QuadMedicine, Inc. (KOSDAQ:464490)
South Korea · Delayed Price · Currency is KRW 13,170
-1,130 (-7.90%)
At close: Apr 2, 2026
QuadMedicine Market Cap
QuadMedicine has a market cap or net worth of 151.22 billion as of April 2, 2026.
Market Cap
151.22B
Enterprise Value
131.19B
Revenue
10.70B
Ranking
n/a
PE Ratio
n/a
Stock Price
13,170.00
Market Cap Chart
Since December 12, 2025, QuadMedicine's market cap has decreased from 199.95B to 151.22B, a decrease of -24.37%. That is a compound annual growth rate of -60.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 164.19B | -7.14% |
| Dec 30, 2025 | 176.81B | -11.57% |
| Dec 12, 2025 | 199.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABION | 219.85B |
| Prestige Biologics | 190.88B |
| ISU Abxis | 188.95B |
| Ensol Biosciences | 187.09B |
| NovMetaPharma | 121.35B |
| BIO-FD&C | 116.70B |
| KoBioLabs | 115.54B |
| ViGenCell | 113.16B |